BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32019973)

  • 1. A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis framework.
    Hoare SRJ; Tewson PH; Quinn AM; Hughes TE
    Sci Rep; 2020 Feb; 10(1):1766. PubMed ID: 32019973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
    Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
    J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor.
    Gaidarov I; Adams J; Frazer J; Anthony T; Chen X; Gatlin J; Semple G; Unett DJ
    Cell Signal; 2018 Oct; 50():9-24. PubMed ID: 29928987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
    Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
    J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors.
    Brulé C; Perzo N; Joubert JE; Sainsily X; Leduc R; Castel H; Prézeau L
    FASEB J; 2014 Dec; 28(12):5148-62. PubMed ID: 25183668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic operational models of agonism for G-protein-coupled receptors.
    Hoare SRJ; Pierre N; Moya AG; Larson B
    J Theor Biol; 2018 Jun; 446():168-204. PubMed ID: 29486201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
    M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
    J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into Arrestin Recruitment to GPCRs.
    Spillmann M; Thurner L; Romantini N; Zimmermann M; Meger B; Behe M; Waldhoer M; Schertler GFX; Berger P
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
    Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
    J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased agonism as a mechanism for differential signaling by chemokine receptors.
    Rajagopal S; Bassoni DL; Campbell JJ; Gerard NP; Gerard C; Wehrman TS
    J Biol Chem; 2013 Dec; 288(49):35039-48. PubMed ID: 24145037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
    Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
    Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying biased signaling in GPCRs using BRET-based biosensors.
    Namkung Y; Radresa O; Armando S; Devost D; Beautrait A; Le Gouill C; Laporte SA
    Methods; 2016 Jan; 92():5-10. PubMed ID: 25890247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
    Galandrin S; Denis C; Boularan C; Marie J; M'Kadmi C; Pilette C; Dubroca C; Nicaise Y; Seguelas MH; N'Guyen D; Banères JL; Pathak A; Sénard JM; Galés C
    Hypertension; 2016 Dec; 68(6):1365-1374. PubMed ID: 27698068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
    Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
    J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased signaling at chemokine receptors.
    Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
    J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle.
    Nuber S; Zabel U; Lorenz K; Nuber A; Milligan G; Tobin AB; Lohse MJ; Hoffmann C
    Nature; 2016 Mar; 531(7596):661-4. PubMed ID: 27007855
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.